Goldman Sachs Group Inc Valens Company, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 May 14, 2024	BUY	$0.64 - $1.02 $732 - $1,166	1,144 Added 3.64%	32,564 $21,000
Q4 2022 Feb 13, 2023	BUY	$0.64 - $1.02 $732 - $1,166	1,144 Added 3.64%	32,564 $21,000
Q2 2022 May 14, 2024	BUY	$0.61 - $1.69 $19,166 - $53,099	31,420 New	31,420 $20,000
Q2 2022 Aug 15, 2022	SELL	$0.61 - $1.69 $365 - $1,012	-599 Reduced 1.87%	31,420 $20,000
Q1 2022 May 16, 2022	BUY	$1.69 - $2.82 $31,995 - $53,388	18,932 Added 144.66%	32,019 $55,000
Q4 2021 Feb 14, 2022	BUY	$2.4 - $3.18 $31,408 - $41,616	13,087 New	13,087 $32,000

Others Institutions Holding VLNS

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Valens Company, Inc.

Ticker VLNS
Exchange NASDAQ
Description
The Valens Company Inc. develops, manufactures, and sells cannabinoid-based products in Canada and internationally. It produces dried cannabis and hemp biomass products. The company also provides a range of products, including tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, concentrates, topicals, edibles,...

More about VLNS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.